• Publications
  • Influence
Leukocytapheresis with leukocyte removal filter as new therapy for ulcerative colitis.
Leukocytapheresis (LCAP) with a leukocyte removal filter column was administered for 45 patients with ulcerative colitis (UC). We evaluated changes in the leukocyte count and the differentialExpand
  • 80
  • 8
Effect of leukocytapheresis therapy using a leukocyte removal filter in Crohn's disease.
Eighteen patients with active Crohn's disease were treated with one leukocytapheresis session per week for a five-week intensive therapy, decreasing to one leukocytapheresis session per month forExpand
  • 39
  • 2
Complications of leukocytapheresis.
Recently leukocytapheresis (LCAP) has attracted attention as a new therapy for ulcerative colitis. We reviewed the complications associated with LCAP carried out in our department during the periodExpand
  • 37
Family aggregation of carcinoma of the hypopharynx and cervical esophagus: Special reference to multiplicity of cancer in upper aerodigestive tract
The role of family history in the multiple occurrence of cancer in the upper aerodigestive tract (UADT) remains unclear. The family histories of close relatives were examined in 167 patients withExpand
  • 35
Leukocytapheresis (LCAP) for Management of Fulminant Ulcerative Colitis with Toxic Megacolon
Leukocytapheresis (LCAP) is a method of therapeutic apheresis to remove patients’ peripheral leukocytes by extracorporeal circulation. Previous studies showed that LCAP for the treatment ofExpand
  • 28
Exacerbated autoimmune hepatitis successfully treated with leukocytapheresis and bilirubin adsorption therapy
A 58-year-old man with subacute fulminant onset of autoimmune hepatitis (AIH) was treated by leukocytapheresis (LCAP) and bilirubin adsorption therapy (BAT), rather than by administration of highdoseExpand
  • 9
[Leukocytapheresis for ulcerative colitis].
Leukocytapheresis(LCAP) and Granulocytapheresis(GCAP) are classified as extracorporeal circulation therapy(ECCT). These therapies are a novel, effective way to treat patients with ulcerativeExpand
  • 5
[Mechanism of leukocytapheresis effect in the treatment of ulcerative colitis].
To solve adverse effects of high dose steroid administration for patients with moderately severe and severe ulcerative colitis (UC), additional use of leukocytapheresis (LCAP) was tried to settleExpand
  • 3
[Leukocytapheresis for ulcerative colitis].
Major inclusion criteria for leukocytapheresis (LCAP) therapy were mainly insufficient response to conventional drugs therapy. LCAP was administered once a week for 5 weeks of intensive therapy andExpand
  • 2